Cannara Biotech Inc. (TSX:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.870
+0.030 (1.63%)
At close: Mar 4, 2026

Cannara Biotech Income Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
112.36107.3282.1557.563617.27
Revenue Growth (YoY)
28.06%30.64%42.71%59.91%108.48%723.43%
Cost of Revenue
45.2160.151.9636.4921.858.53
Gross Profit
48.2547.2230.1927.5317.4910.54
Selling, General & Admin
17.6823.1719.6513.5210.037.3
Depreciation & Amortization Expenses
1.281.561.380.961.231.03
Research & Development
0.540.711.121.031.261.91
Other Operating Expenses
-0.42-0.41-2.030.130.060.09
Operating Income
20.6722.210.0811.894.940.26
Interest Expense
-3.56-4.1-5.59-4.94-2.64-1.79
Total Non-Operating Income (Expense)
-3.56-4.1-5.59-4.94-2.64-1.79
Pretax Income
17.118.14.486.952.31-1.53
Provision for Income Taxes
-4.29-5.021.95---
Net Income
11.8113.086.446.952.31-1.53
Net Income to Common
11.8113.086.446.952.31-1.53
Net Income Growth
77.94%103.09%-7.30%201.26%--
Shares Outstanding (Basic)
929190898877
Shares Outstanding (Diluted)
949291908877
Shares Change (YoY)
1.95%1.08%1.83%2.16%14.80%24.45%
EPS (Basic)
0.130.140.070.080.03-0.10
EPS (Diluted)
0.120.140.070.080.03-0.10
EPS Growth
71.43%100.00%-12.50%166.67%--
Free Cash Flow
-13.653.21-3.97-21.55-33.17
Free Cash Flow Growth
-324.86%----
Free Cash Flow Per Share
-0.150.04-0.04-0.25-0.43
Gross Margin
42.94%44.00%36.75%47.83%48.58%61.06%
Operating Margin
18.39%20.68%12.27%20.65%13.73%1.49%
Profit Margin
10.51%12.18%7.84%12.07%6.40%-8.85%
FCF Margin
-12.72%3.91%-6.89%-59.85%-192.08%
EBITDA
20.6728.8816.4316.838.863.28
EBITDA Margin
18.39%26.91%20.00%29.24%24.62%19.02%
EBIT
20.6722.210.0811.894.940.26
EBIT Margin
18.39%20.68%12.27%20.65%13.73%1.49%
Effective Tax Rate
-25.10%-27.74%43.59%0.00%0.00%0.00%
Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.